Dyadic International (DYAI) Stock Price, Quote & News

Company Profile

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large...

Industry: Biotechnology

Sector: Healthcare

Phone: 561 743 8333

Fax: 561 743 8343

Website: www.dyadic.com

Address:

1044 North U.S. Highway One, Suite 201, Jupiter, United States

MikeTechnician May. 12 at 6:07 PM

Dyadic International Inc ($DYAI) Q1 2026: Everything You Need To Know Ahead Of Earnings https://finance.yahoo.com/markets/stocks/articles/dyadic-international-inc-dyai-q1-132313204.html

0 · Reply

MikeTechnician May. 12 at 3:53 PM

$DYAI - https://stockscan.io/stocks/DYAI/

0 · Reply

MikeTechnician May. 12 at 1:58 PM

$DYAI News : Francisco Trust discloses 4.36M-share stake in Dyadic (NASDAQ: DYAI), note amended Dyadic International Inc. reports beneficial ownership by Francisco Trust via Thomas Emalfarb, Trustee. The filing states Francisco Trust beneficially owns 4,363,045 shares (11.97%) of common stock. The trust also holds 952,381 shares issuable upon conversion of a Convertible Note amended to a $1.05 conversion price on 12/23/2025, with maturity extended to 12/31/2027. Shares outstanding were 36,438,703 as of 03/24/2026. https://www.stocktitan.net/sec-filings/DYAI/schedule-13g-a-dyadic-international-inc-amended-passive-investment-di-cf2067d5163f.html

0 · Reply

STOCKSGambino May. 11 at 8:41 PM

$DYAI https://x.com/StocksGambino/status/2053938106798145828

0 · Reply

MikeTechnician May. 11 at 6:02 PM

$DYAI - Analysts Expect Breakeven For Dyadic International, Inc. (NASDAQ:DYAI) Before Long https://finance.yahoo.com/markets/stocks/articles/analysts-expect-breakeven-dyadic-international-122804108.html

0 · Reply

MikeTechnician May. 11 at 1:24 PM

$DYAI News : Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026 JUPITER, Fla., April 29, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for use in life sciences, food and nutrition, and industrial biotechnology applications utilizing its proprietary gene expression platforms, today announced that it will report its financial results for the quarter ended March 31, 2026 and host a corporate update conference call on Wednesday, May 13, 2026. https://finance.yahoo.com/sectors/healthcare/articles/dyadic-report-q1-2026-financial-200500766.html

0 · Reply

STOCKSGambino May. 8 at 10:12 PM

$DYAI https://x.com/StocksGambino/status/2052874086657749150

0 · Reply

STOCKSGambino May. 8 at 9:19 PM

$DYAI https://x.com/StocksGambino/status/2052858547290189961

0 · Reply

STOCKSGambino May. 8 at 5:56 PM

$DYAI https://x.com/StocksGambino/status/2052809825071854011

0 · Reply

SmallCapGrowth May. 7 at 6:21 PM

$DYAI — Dyadic Applied BioSolutions - BREAKOUTS..RUNNERS AND HOT PENNIES https://investorshangout.com/post/view?id=6828424

0 · Reply

Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026

Mar 25, 2026, 5:00 PM EDT - 6 weeks ago

Dyadic International Earnings Call Transcript: Q4 2025

Mar 25, 2026, 4:51 PM EDT - 6 weeks ago

Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress

2026-03-16T11:36:49.000Z - 2 months ago

Dyadic International enter distribution partnership with IBT Bioservices

Mar 16, 2026, 7:20 AM EDT - 2 months ago

Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices

Mar 12, 2026, 1:30 PM EDT - 2 months ago

Dyadic International Transcript: Life Sciences Virtual Investor Forum

Mar 11, 2026, 4:10 PM EDT - 2 months ago

Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026

2026-03-04T12:23:22.000Z - 2 months ago

Dyadic International, Fermbox Bio launch of RNase-Free

Mar 4, 2026, 7:20 AM EST - 2 months ago

Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)

2026-03-02T12:33:34.000Z - 2 months ago

Dyadic International, Inzymes announce planned 2026 commercialization

2026-03-02T12:29:56.000Z - 2 months ago

Dyadic International, Inzymes announce planned 2026 commercialization

Mar 2, 2026, 7:20 AM EST - 2 months ago

Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone

Feb 17, 2026, 7:25 AM EST - 3 months ago

Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin

2025-12-17T12:26:09.000Z - 5 months ago

Dyadic International, Fermbox Bio expand strategic collaboration

2025-12-15T12:25:44.000Z - 5 months ago

Dyadic International establishes commercial partnership with Opes

Dec 15, 2025, 7:20 AM EST - 5 months ago

Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic's Recombinant Growth Factors and Media Proteins

Dec 9, 2025, 9:30 AM EST - 5 months ago

Dyadic International Transcript: IAccess Alpha Virtual MicroCap Conference

Dec 1, 2025, 7:25 AM EST - 5 months ago

Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets

2025-11-12T22:30:23.000Z - 6 months ago

Dyadic International reports Q3 EPS (6c), consensus (4c)

Nov 12, 2025, 5:00 PM EST - 6 months ago

Dyadic International Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:05 PM EST - 6 months ago

Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress

2025-11-10T12:38:06.000Z - 6 months ago

Dyadic International, ERS Genomics announces CRISPR/Cas9 license

Oct 29, 2025, 7:25 AM EDT - 7 months ago

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

2025-10-23T10:10:55.000Z - 7 months ago

Dyadic International assumed with a Buy at H.C. Wainwright

2025-10-06T12:50:17.000Z - 7 months ago

Dyadic International announces achievement of milestone payments

Oct 6, 2025, 8:30 AM EDT - 7 months ago

Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments

Sep 18, 2025, 9:15 AM EDT - 8 months ago

Dyadic International Transcript: Small-Cap Virtual Conference

2025-09-08T13:20:27.000Z - 8 months ago

Craig-Hallum bullish on Dyadic International, initiates with a Buy

2025-09-08T11:20:43.000Z - 8 months ago

Dyadic International initiated with a Buy at Craig-Hallum

Sep 4, 2025, 9:00 AM EDT - 8 months ago

Dyadic to Present at Investor Conferences and BPI East

Aug 13, 2025, 5:00 PM EDT - 9 months ago

Dyadic International Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:01 PM EDT - 9 months ago

Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

Aug 5, 2025, 4:11 PM EDT - 10 months ago

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

2025-07-31T12:50:32.000Z - 10 months ago

Dyadic International prices 6.05M shares at 95c in underwritten public offering

Jul 31, 2025, 8:47 AM EDT - 10 months ago

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

2025-07-31T11:41:14.000Z - 10 months ago

Dyadic International prices 6.05M shares in underwritten public offering

Jul 31, 2025, 7:30 AM EDT - 10 months ago

Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

2025-07-30T20:13:50.000Z - 10 months ago

Dyadic International announces common stock offering, no amount given

Jul 30, 2025, 4:02 PM EDT - 10 months ago

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

2025-07-02T20:05:15.000Z - 11 months ago

Dyadic International rebrands as Dyadic Applied BioSolutions

Jul 2, 2025, 4:00 PM EDT - 11 months ago

Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions

2025-06-02T12:45:52.000Z - 1 year ago

Dyadic International names Joe Hazelton as President

Jun 2, 2025, 8:35 AM EDT - 1 year ago

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

May 14, 2025, 5:00 PM EDT - 1 year ago

Dyadic International Earnings Call Transcript: Q1 2025

May 1, 2025, 3:00 PM EDT - 1 year ago

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

Apr 16, 2025, 2:00 PM EDT - 1 year ago

Dyadic to Present at World Vaccine Congress | Washington

Mar 26, 2025, 5:00 PM EDT - 1 year ago

Dyadic International Earnings Call Transcript: Q4 2024

2025-03-26T20:15:40.000Z - 1 year ago

Dyadic International files to sell 840K shares of common stock for holders

Mar 26, 2025, 4:05 PM EDT - 1 year ago

Dyadic Reports 2024 Year-End Financial Results and Business Updates

Mar 12, 2025, 4:00 PM EDT - 1 year ago

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

Mar 6, 2025, 8:30 AM EST - 1 year ago

Dyadic to Attend Multiple Industry Events in March

Jan 6, 2025, 8:30 AM EST - 1 year ago

Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

Nov 21, 2024, 8:30 AM EST - 1 year ago

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

Nov 12, 2024, 5:00 PM EST - 1 year ago

Dyadic International Earnings Call Transcript: Q3 2024

Nov 4, 2024, 4:30 PM EST - 1 year ago

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Oct 9, 2024, 8:00 AM EDT - 1 year ago

Dyadic Expands Global Presence with Participation in Key Industry Events

Sep 23, 2024, 9:50 AM EDT - 1 year ago

Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference

Aug 13, 2024, 5:00 PM EDT - 1 year ago

Dyadic International Earnings Call Transcript: Q2 2024

Jul 30, 2024, 4:00 PM EDT - 1 year ago

Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024

Jun 28, 2024, 8:30 AM EDT - 2 years ago

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

May 30, 2024, 4:30 PM EDT - 2 years ago

Dyadic to Attend Industry Events in June

May 14, 2024, 5:00 PM EDT - 2 years ago

Dyadic International Earnings Call Transcript: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

May 8, 2024, 8:30 AM EDT - 2 years ago

Dyadic to Attend Industry and Investor Events in May

Apr 30, 2024, 4:30 PM EDT - 2 years ago

Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

Mar 28, 2024, 5:00 PM EDT - 2 years ago

Dyadic International Earnings Call Transcript: Q4 2023

Mar 28, 2024, 4:00 PM EDT - 2 years ago

Dyadic Reports 2023 Full Year Results and Recent Company Progress

Mar 28, 2024, 8:30 AM EDT - 2 years ago

Dyadic Announces Change in Board and Management Leadership Roles

Mar 27, 2024, 8:30 AM EDT - 2 years ago

Dyadic to Attend Industry Events in April

Mar 26, 2024, 8:30 AM EDT - 2 years ago

Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications

Mar 21, 2024, 8:30 AM EDT - 2 years ago

Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California

Mar 14, 2024, 4:30 PM EDT - 2 years ago

Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024

Mar 11, 2024, 9:57 AM EDT - 2 years ago

CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

Mar 11, 2024, 8:30 AM EDT - 2 years ago

Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

Mar 1, 2024, 8:30 AM EST - 2 years ago

Dyadic to Attend Industry Events in March

Feb 28, 2024, 8:30 AM EST - 2 years ago

Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform

Feb 23, 2024, 2:00 AM EST - 2 years ago

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

Feb 21, 2024, 8:30 AM EST - 2 years ago

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

Feb 13, 2024, 8:30 AM EST - 2 years ago

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

Feb 6, 2024, 8:30 AM EST - 2 years ago

Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company

MikeTechnician May. 12 at 6:07 PM

Dyadic International Inc ($DYAI) Q1 2026: Everything You Need To Know Ahead Of Earnings https://finance.yahoo.com/markets/stocks/articles/dyadic-international-inc-dyai-q1-132313204.html

0 · Reply

MikeTechnician May. 12 at 3:53 PM

$DYAI - https://stockscan.io/stocks/DYAI/

0 · Reply

MikeTechnician May. 12 at 1:58 PM

0 · Reply

STOCKSGambino May. 11 at 8:41 PM

$DYAI https://x.com/StocksGambino/status/2053938106798145828

0 · Reply

MikeTechnician May. 11 at 6:02 PM

0 · Reply

MikeTechnician May. 11 at 1:24 PM

0 · Reply

STOCKSGambino May. 8 at 10:12 PM

$DYAI https://x.com/StocksGambino/status/2052874086657749150

0 · Reply

STOCKSGambino May. 8 at 9:19 PM

$DYAI https://x.com/StocksGambino/status/2052858547290189961

0 · Reply

STOCKSGambino May. 8 at 5:56 PM

$DYAI https://x.com/StocksGambino/status/2052809825071854011

0 · Reply

SmallCapGrowth May. 7 at 6:21 PM

$DYAI — Dyadic Applied BioSolutions - BREAKOUTS..RUNNERS AND HOT PENNIES https://investorshangout.com/post/view?id=6828424

0 · Reply

SmallCapGrowth May. 7 at 3:50 PM

$DYAI #NASDAQ The Engine of Innovation: Dyadic and Proliant’s Commercial Breakthrough https://www.youtube.com/watch?v=AFbJ_3uuzLU&t=20s #DYAI #Biotech #StockAlert #Investing @thebullrunshow

0 · Reply

SmallCapGrowth May. 7 at 2:45 PM

MOMO'S BREAKOUT BOARD : 🚨 $DYAI — Dyadic Applied BioSolu... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177579328 via @Investors_Hub

0 · Reply

SmallCapGrowth May. 7 at 1:12 PM

🚨 $DYAI — Dyadic Applied BioSolutions is accelerating commercial momentum with product launches and new partnerships. Quick 2-min read: https://wix.to/W5vEilH #DYAI #Biotech #StockAlert #Investing @thebullrunshow

0 · Reply

SmallCapGrowth May. 5 at 5:46 PM

$DYAI Alert: Dyadic Applied BioSolutions - BREAKOUTS..RUNNERS AND HOT PENNIES https://investorshangout.com/post/view?id=6828053

0 · Reply

SmallCapGrowth May. 5 at 3:31 PM

🚨 $DYAI Alert: Dyadic Applied BioSolutions is building a commercial catalyst stack — new launches, partnerships, and momentum toward product revenue. Read more: https://wix.to/yoHNqJp #DYAI #Biotech #DNA #nvax #cdxs @thebullrunshow

0 · Reply

SmallCapGrowth May. 5 at 2:54 PM

0 · Reply

SmallCapGrowth May. 5 at 2:48 PM

MOMO'S BREAKOUT BOARD : 🚨 $DYAI Alert: Dyadic Applied Bi... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177571204 via @Investors_Hub @TheBullRunShow

0 · Reply

MikeTechnician May. 5 at 2:33 PM

$DYAI

1 · Reply

SmallCapGrowth May. 5 at 1:47 PM

🚨 $DYAI Alert: Dyadic Applied BioSolutions is building a commercial catalyst stack — new launches, partnerships, and momentum toward product revenue. Quick read on what’s driving the move: https://wix.to/yoHNqJp #DYAI #Biotech #DNA #nvax #cdxs @thebullrunshow

0 · Reply

SmallCapGrowth May. 5 at 1:34 PM

0 · Reply

WallStreetSignals May. 5 at 1:22 PM

$DYAI Dyadic International Inc. is driving the change to unlock scale, access, and impact for a sustainable global economy. https://dyadic.com/ #TheBullRunShow #DYAI $VRME $VMAR #VISL #DNA #NVAX #CDXS #SustainableFuture #GlobalImpact #DyadicInternational #FeedFuelHeal

0 · Reply

WallStreetSignals May. 4 at 4:47 PM

Make sure to keep Dyadic International Inc. (NASDAQ: $DYAI ) on your radar and capitalize on every chance to stay updated about the stock! For the latest insights and developments, visit https://dyadic.com/ today. #TheBullRunShow #DYAI $VISL $VMAR $TAAG #Investing #StockMarket #Finance #NASDAQ

0 · Reply

Market Cap	26.39M
Revenue (ttm)	3.09M
Net Income (ttm)	-7.36M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-238.19%
Debt to Equity Ratio	0.00

Volume	43,200
Avg Vol	84,772
Day's Range	N/A - N/A
Shares Out	36.44M
Stochastic %K	22%
Beta	1.18
Analysts	Strong Sell
Price Target	$6.00